Dr. Nikhil Agarwal, MD

Dr. Agarwal practices at Surgery Center San Carlos in San Carlos, California.

Dr. Agarwal's NPI, 1487831145, was assigned on January 24, 2008. Dr. Agarwal graduated from Drexel University College Of Medicine in 2006. Dr. Agarwal holds California license A102503.

Dr. Agarwal's primary practice is Surgery Center San Carlos, at 301 Industrial Road Suite 1se, San Carlos, CA 94070.

Dr. Agarwal's primary practice is Surgery Center San Carlos in San Carlos, California. Dr. Agarwal is also affiliated with Mills-Peninsula Medical Center. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Agarwal to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agarwal practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Agarwal's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Agarwal is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Agarwal is licensed in California.

Dmand AI lists acid reflux, chronic indigestion, chronic inflammatory bowel disease (IBD), colonoscopy, gastroenteritis, gastrointestinal bleeding, intestinal or bowel obstruction and irritable bowel syndrome (IBS) among the conditions Dr. Agarwal treats.

CMS data shows 650 Medicare services from Dr. Agarwal across 14 procedure codes in 2024, for 371 Medicare patients. Medicare paid $112,820 for them.

CMS counts 371 Medicare patients who saw Dr. Agarwal in 2024. The largest group is 65 to 74, with 172 patients. 71% of them have high cholesterol, and 56% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Agarwal's median patient age at 54, with 52% women.

In 2024, Dr. Agarwal wrote 785 Medicare Part D claims for 299 patients. 67% of them were for generic drugs. CMS names the drug for 567 of them, across 12 drugs with 11 or more claims each, at $129,489 in total drug cost. In 2023, CMS named 588 claims across 15 drugs.

Dr. Agarwal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Agarwal as offering telehealth. CMS counts 157 procedures of colonoscopy by Dr. Agarwal, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Agarwal, published from 2016 to 2018. Dr. Agarwal's most frequent co-authors are Mimi Lin, MD, Patrick Kai-Ming McCabe, MD and Mona Rezapour, MD.

CMS Open Payments shows 410 general payments to Dr. Agarwal from 36 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 69% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $44,985.

Dr. Agarwal graduated from Drexel University College Of Medicine in 2006.

Dr. Agarwal is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.